NOX4 and acute myeloid leukemia: Neither Nox4 overexpression, nor pervading high levels of ROS or NO within BM, were reversed by conventional chemotherapy in this model, and persisting high NO levels in post-treatment BM samples from primary AML patients was strongly predictive for treatment failure.